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INTRODUCTION 
        
         
 Stroke is a leading cause of death and disability in developing 
countries, afflicting individuals at all ages. Diabetes, being a major risk 
factor for stroke and with its increasing prevalence in India, has 
contributed alarmingly to the increase in the prevalence of stroke rate. 
Metabolic syndrome, a clustering of disturbed glucose and insulin 
metabolism, obesity and abdominal fat distribution, dyslipidemia, and 
hypertension is gaining recognition as an important independent risk 
factor for vascular disease and stroke. Because of its strong association 
with diabetes, it is often considered as a prediabetic condition.  
          
         Foreign studies have shown that men with the condition have a 78 
percent greater stroke risk and similarly women with the condition have 
more than double the stroke risk of women who do not have the 
syndrome.  Also it is shown that treating the risk-factor components of 
metabolic syndrome might reduce stroke risk before the onset of Type 2 
diabetes. However, the contribution of its established components to 
ischemic stroke in adults has not been evaluated systematically in 
Indians. So it was proposed to examine the relationship of metabolic 
syndrome, as defined by modified National Cholesterol Education 
Program (NCEP) criteria with the risk for stroke.  
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DEFINITION OF METABOLIC SYNDROME ACCORDING TO 
THE WHO, NCEP ATP III, AND IDF 
Factor 
WHO  
(main criterion+ 
2 factors)* 
NCEP ATP III  
(any combination 
of 3 factors) 
IDF  
(main criterion 
+ 2 factors) 
 
BMI (kg/m2) >30 — — 
Abdominal obesity 
(men/women) 
Waist-to-hip ratio 
>0.9/0.85 
Waist >102/88 cm Waist >94/80 
cm  
Triglycerides (mg/dl) 150 150 150 
HDL cholesterol 
(mg/dl) (men/women) 
<35/39 <40/50 <40/50 
Blood pressure 
(mmHg) 
140/ 90 130/ 85 140/>90 or 
>130/>85 
HOMA  >4.3 — — 
Type 2 diabetes Present — Present 
Fasting glucose 
(mg/dl) 
110 110 100 
Fasting insulin — — — 
Urinary albumin 
excretion 
20 µg/min or  
30 mg/g albumin 
creatinine ratio 
— — 
 
WHO- World Health Organization, 
NCEP ATPIII-The National Cholesterol Education Program Adult 
                        Treatment Panel III (2001)  
IDF- International Diabetes Federation 
HOMA- Homeostasis model assessment, as a simple method for 
              determining insulin sensitivity in humans; calculated as 
             Fasting insulin ×fasting glucose (mmol/L) / 22.5 
BMI- Body mass index 
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 Sines qua nonfactors are in bold.  
 * According to the WHO, either BMI or abdominal obesity 
represents one criterion.  
 Ethnic group waist circumference (as measure of central obesity): 
Europid men 94 and women 80 cm; South Asian men 90 and 
women 80 cm; Chinese men 90 and women 80 cm; and 
Japanese men 85 and women 90 cm. Ethnic South and Central 
American populations use South Asian recommendations until 
more specific data are available. Sub-Saharan African populations 
use European data until more specific data are available. Eastern 
Mediterranean and Middle East (Arab) populations use European 
data until more specific data are available.  
 According to the WHO, HOMA, type 2 diabetes, and fasting 
glucose are alternatives, fulfilling one criterion.  
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Aim of the Study 
 
AIM OF THE STUDY 
 
   
 
 
 
 
  
  
 
 
1) To study the prevalence of metabolic syndrome in 100 stroke 
patients.  
 
2) To study the role of various components of metabolic syndrome 
(modified ATP III criteria) in causation of stroke.  
 
3) To assess the association between the metabolic syndrome and 
cerebrovascular accidents. 
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REVIEW OF LITERATURE 
 
 
STROKE 
World Health Organization has defined stroke1 as “neurological 
deficit of cerebrovascular cause that persists beyond 24 hours or is 
interrupted by death within 24 hours”. 
CLASSIFICATION OF CEREBROVASCULAR DISEASE3 
 
 
Types of stroke2 
i) Ischemic - can be due to thrombosis, embolism, or systemic 
hypoperfusion (Watershed or Border Zone stroke), or venous 
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thrombosis. Cocaine abuse doubles the risk of ischemic strokes4. 
80% of strokes are due to ischemia. 
ii) Hemorrhage - can be due to intracerebral hemorrhage, 
subarachnoid hemorrhage, subdural hemorrhage, or epidural 
hemorrhage. Amphetamine abuse quintuples and cocaine abuse 
doubles the risk of hemorrhagic strokes5. 
 
Thrombotic stroke 
In thrombotic stroke, a thrombus-forming process develops around 
atherosclerotic plaques in the affected artery which gradually narrows the 
lumen of the artery and impedes blood flow to distal tissue. Since 
blockage of the artery is gradual, onset of symptomatic thrombotic 
strokes is slower. A thrombus itself (even if non-occluding) can lead to an 
embolic stroke if the thrombus breaks off-at which point it is then called 
an "embolus." Thrombotic stroke can be divided into two types 
depending on the type of involved vessel:  
a) Large vessel disease - involves the common and internal 
carotids, vertebral, and the Circle of Willis. Causes include: 
o Atherosclerosis 
o Dissection  
o Takayasu & Giant cell arteritis  
o Moyamoya syndrome &Fibromuscular dysplasia  
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         b) Small vessel disease - involves the intracerebral arteries, 
branches of the Circle of Willis, middle cerebral artery, stem, and arteries 
arising from the distal vertebral and basilar artery.  
o Lipohyalinosis (lipid hyaline build-up secondary to hypertension 
and aging) and fibrinoid degeneration (stroke involving these 
vessels are known as lacunar infarcts)  
o Microatheromas from larger arteries that extend into the smaller 
arteries (atheromatous branch disease)  
 
Embolic stroke2 
  It refers to the blockage of arterial access to a part of the brain by 
an embolus—a traveling particle or debris in the arterial bloodstream 
originating from elsewhere which could either be a blood clot, a ruptured 
plaque or fat (e.g., from bone marrow in a broken bone), air, infected 
particle and even cancerous cells. 
Because the embolic blockage is sudden in onset, symptoms 
usually are maximal at start. Also, symptoms may be transient as the 
embolus lyses and moves to a different location or dissipates altogether. 
Common causes include4: 
• Atrial fibrillation and Sustained atrial flutter  
• Rheumatic mitral or aortic valve disease  
• Bioprosthetic and mechanical heart valves  
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• Atrial or ventricular thrombus;  Papillary fibroelastoma & Left 
atrial myxoma  
• Sick sinus syndrome  
• Recent myocardial infarction (within one month) &Coronary artery 
bypass graft (CABG) surgery  
• Symptomatic congestive heart failure with ejection fraction <30 
percent and Dilated cardiomyopathy  
• Libman-Sacks, Infective & Marantic endocarditis  
• Antiphospholipid syndrome  
• Complex atheroma in the ascending aorta or proximal arch  
Systemic hypoperfusion (Watershed stroke) 
Systemic hypoperfusion is the reduction of blood flow to all parts of the 
body including brain especially "watershed" areas --- border zone regions 
supplied by the major cerebral arteries. It is most commonly due to  
1) cardiac pump failure from cardiac arrest or arrhythmias, or from 
reduced cardiac output as a result of myocardial infarction, 
pulmonary embolism, pericardial effusion, or bleeding.  
2) Hypoxemia.  
 
Hemorrhagic stroke2 
A hemorrhagic stroke, or cerebral hemorrhage occurs when a blood 
vessel in the brain ruptures or bleeds. This interrupts the brain's blood 
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supply and if the bleeding continues, it can cause increased intracranial 
pressure. In addition, blood irritates brain tissue, disrupting the delicate 
chemical balance. In this respect, hemorrhagic strokes are more 
dangerous than their more common counterpart, ischemic strokes.   
 
ISCHEMIC/EMBOLIC STROKE 
A. ANATOMY3 
1.  Carotid Artery distribution-carotid arteries perfuse the majority of 
the cerebrum. Common Carotid Artery on either side divides into the 
Internal Carotid Artery and the External Carotid Artery. Internal 
Carotid Artery then divides into Anterior Cerebral Artery (ACA) and 
the Middle Cerebral Artery (MCA).  
a.    ACA-supplies the medial surface of the frontal lobe, parietal lobe and 
occipital lobe 
b.  MCA-the largest branch of the internal carotid artery  
2.  Vertebrobasilar Artery distribution-perfuses the base of cerebrum and 
majority of cerebellum. 
 Two Vertebral Arteries join to form the Basilar Artery. Branching 
from the Basilar Artery are the 2 Posterior Cerebral Arteries (PCA). 
a.  Basilar Artery and PCA supply the occipital lobe, brain stem and 
cerebellum. 
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Fig - 1 ANTERIOR CEREBRAL ARTERY 
 
 
 
 
 
Fig - 2 MIDDLE CEREBRAL ARTERY 
 
 
 
 
 
   
 
 
 
 
  
  
 
 
Fig - 3 POSTERIOR CEREBRAL ARTERY 
 
 
 
 
 
 
 
Fig - 4 ARTERIAL CIRCLE OF WILLIS 
 
 
 
 
   
 
 
 
 
  
  
 
Fig.5 Various Sites of thrombo-embolic phenomena3 
 
 
 
B. CLASSIFICATION OF ISCHEMIC EVENTS3 
(These are based on the temporal course and eventual outcome). 
1. Transient Ischemic Attacks (TIAs) 
They are episodes of temporary reduction in perfusion to a focal 
region of the brain causing a short-lived disturbance of function. The 
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patient experiences a temporary focal neurological deficit such as slurred 
speech, aphasia, amaurosis fugax (monocular blindness), weakness or 
paralysis of a limb. The onset is rapid, usually less than 5 minutes and 
duration is usually 2-15 minutes but can last up to 24 hours. No 
neurological deficit remains after the attack & can vary from one episode 
in a lifetime to > 20 in one day. It may be the only warning of an 
impending stroke. 
2. Reversible Ischemic Neurological Deficit (RIND) 
Focal brain ischemia in which the deficit improves over a maximum of 72 
hours and deficits may not completely resolve in all cases. 
3. Cerebral Infarction 
Permanent neurological disorder, the patient presents with fixed deficits; 
can present in 3 forms: 
1.  Stable - the neurological deficit is permanent and will not improve 
                    or deteriorate. 
2.   Improving - return of previously lost neurological function over  
                           several days to weeks. 
3.   Progressing- the neurological status continues to deteriorate  
                           following the initial onset of focal deficits, may see a  
                           stabilization period, followed by further progression. 
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C. PATHOPHYSIOLOGY 
1.  Atherosclerosis and subsequent plaque formation results in arterial 
narrowing or occlusion and predispose to thrombus formation. 
2.  Platelet Aggregation 
a. Vessel wall injury→ exposed sub endothelium→ triggers platelet 
activation  
b. Release of ADP from activated platelets causes platelet 
aggregation. 
c.  Consolidation of platelet-plug by RBCs, coagulation factors, and 
formation of fibrin network. 
e. Thromboxane A2 (TX A2) produced by platelets and 
endothelium promote platelet aggregation and vasoconstriction. 
3.  Coagulation Cascade 
a. is a series of enzyme complexes located on the surface of 
platelets and endothelium which lead to thrombin production. 
b. Thrombin (IIa) then converts Fibrinogen to Fibrin. 
 
Risk Factors for Stroke 
• Hypertension & Diabetes 
• Heart disease esp. atrial fibrillation  
• Cigarette smoking  
• Transient ischemic attacks 
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• Increased serum cholesterol / lipids  
• Physical inactivity  
• Obesity 
• Excessive alcohol intake / drug abuse  
 
METABOLIC SYNDROME 
It is a prediabetic aggregation of symptoms and a more prevalent 
risk factor for stroke than is type 2 diabetes mellitus6. India is already the 
“Diabetes Capital” of the world and by the year 2020, is projected to have 
the highest number of individuals suffering from atherothrombotic 
cardiovascular disease7.This concept was proposed to highlight the             
co-occurrence of risk factors for coronary heart disease (CHD) and type 2 
diabetes. Subsequently, epidemiological studies have confirmed that this 
syndrome is common in a wide variety of ethnic groups including 
Caucasians, Afro-Americans, Mexican-Americans, Asian Indians, 
Chinese, Australian Aboriginals, Polynesians and Micronesians8. 
 
History 
The term "metabolic syndrome" dates back to at least the late 
1950s, but came into common usage in the late 1970s to describe various 
associations of risk factors with diabetes that had been noted as early as 
the 1920s9, 10. 
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In 1977, Haller used the term "metabolic syndrome" for 
associations of obesity, diabetes mellitus, hyperlipoproteinemia, and 
hyperuricemia and steatosis hepatis when describing the additive effects 
of risk factors on atherosclerosis11.  
 
In 1988, in his Banting lecture, Gerald M. Reaven proposed insulin 
resistance as the underlying factor and named the constellation of 
abnormalities Syndrome X. Reaven did not include abdominal obesity, 
which has also been hypothesized as the underlying factor, as part of the 
condition.12 
 
Various synonyms used are Insulin resistance syndrome, 
Syndrome X, Reaven's syndrome or CHAOS (Australia).Deadly 
quartet of central obesity, hypertension, dyslipidemia (high triglyceride 
and low HDL), and glucose intolerance is now a well-recognised entity. 
 
The clinical manifestations of metabolic syndrome vary in different 
populations. Caucasians mainly show dyslipidemia, African populations 
show hypertension, Native Americans show hyperglycemia and South 
Asians show both hyperglycemia and accelerated coronary artery 
disease.13 
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ATP III14 identified 6 components of the metabolic syndrome that relate 
to CVD:  
• Abdominal obesity  
• Atherogenic dyslipidemia  
• Raised blood pressure  
• Insulin resistance ± glucose intolerance  
• Proinflammatory state  
• Prothrombotic state  
 
Abdominal obesity - most strongly associated with the metabolic 
syndrome. It presents clinically as increased waist circumference. Leptin 
deficiency or resistance leads to tissue deposition of fat. This ectopic 
distribution of fat (triglycerides) particularly its visceral or central 
component causes insulin resistance. Genetic factors are responsible for 
70% of the variation in intra-abdominal fat mass. The other important 
determinant is sex, with males being typified by central and females by 
peripheral fat distribution.  
 
Various theories put forth were: 
1)  “Common soil” theory: it is possible that visceral adiposity and 
metabolic disorders are not causally linked, but the end-result of 
common genetic and environmental factors.  
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2)  Visceral adipocytes are metabolically more active and excess 
adipose tissue lipolysis leads to increased plasma concentrations of 
free fatty acids (FFA). 
 3)  Because of anatomical proximity to liver, metabolic products of 
visceral adipocytes (mainly FFA) drain via the portal venous system 
directly to the liver13.  
 
There is strong evidence to suggest that excess FFA is the cause of 
insulin resistance. There is intracellular accumulation of triglycerides and 
fatty acid metabolites (fatty acid CoA’s, diacylglycerol, and ceramides) in 
the insulin responsive tissues, interfering with upstream insulin signaling 
events in skeletal muscle & liver. Thus, insulin resistance in metabolic 
syndrome is post-receptor in origin. 
 
Atherogenic dyslipidemia - is characterized by 
- Increased triglyceride 
- Decreased HDL cholesterol concentrations 
- Normal concentrations of LDL cholesterol, but preponderance of 
small, dense LDL particles.  
Other lipoprotein abnormalities  eg, increased remnant lipoproteins, 
elevated apolipoprotein B, small LDL particles and small HDL particles 
have also been implicated as being independently atherogenic.  
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Increased hepatic FFA delivery leads to increased triglyceride 
synthesis and subsequently increased hepatic VLDL apoB-100 secretion 
which in turn increases the activity of cholesterol ester transfer protein 
(CETP) causing increased transfer of triglyceride from VLDL to LDL 
and HDL in exchange for cholesterol. These triglyceride-enriched lipo-
proteins are good substrate for the enzyme hepatic lipase, which by 
hydrolysing the triglyceride causes: 
(i) increased clearance of HDL cholesterol from blood, and 
(ii) formation of highly atherogenic, small, dense LDL particles 15.  
        South Asian populations show lower muscle mass and high body fat 
at non-obese body mass index with tendency to central deposition of fat 
since childhood16. 
Elevated blood pressure - strongly associates with obesity and commonly  
occurs in insulin-resistant persons. Hypertension thus commonly is listed 
among metabolic risk factors. Leptin may increase blood pressure by 
causing sympathetic activation.  Renal sodium retention secondary to 
hyperinsulinemia also contributes to hypertension.   
Endothelial dysfunction manifesting as blunting of the biologic 
effect of a potent endothelium-derived vasodilator, nitric oxide, and 
increased production of vasoconstrictors such as angiotensin II, 
endothelin-1, cyclooxygenase and lipooxygenase products of arachidonic 
acid metabolism, seems to be the most important mechanism.  
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Insulin resistance - It is a physiological change in insulin action 
manifesting as resistance to insulin-mediated glucose disposal. It is the 
fundamental defect linking individual components of metabolic 
syndrome, although the strength of association of insulin resistance to 
these components is variable in different populations and even within 
populations. Patients with longstanding insulin resistance frequently 
manifest glucose intolerance, which itself is an independent risk factor for 
CVD17.  
Measurement of insulin resistance18, 19 
The euglycaemic-insulin clamp and the intravenous glucose 
tolerance test (IVGTT) are standard methods for the measurement of 
insulin resistance in research, but are impractical in clinical practice. 
Studies have shown fasting insulin of > 12.2 mU/L to be highly specific 
for insulin resistance. Also TGL /HDL-C concentration ratio is an equally 
powerful predictor of insulin resistance. 
Abnormalities associated with insulin Resistance / hyperinsulinemia. 
1.   Glucose intolerance- Impaired fasting glucose & 
                                        Impaired glucose tolerance 
2.  Abnormal uric acid metabolism- ↑Plasma uric acid concentration &  
                                                             ↓Renal uric acid clearance 
3.  Dyslipidemia - ↑ TGL &post prandial lipemia; ↓HDL-C, LDL 
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4.  Hemodynamic - ↑ Sympathetic activity, Blood Pressure &  
                                   Renal sodium retention 
5.  Haemostatic-     ↑Plasma activator inhibitor-1 & Fibrinogen 
6.  Endothelial dysfunction - ↑Mononuclear cell adhesion  
                                                  ↑Plasma concentration of asymmetric  
       dimethyl - arginine and  
      ↓ Endothelial- dependent vasodilatation 
 7. Reproductive - Polycystic ovary syndrome.  
 
 
A proinflammatory state - recognized clinically by elevated C-reactive 
protein (CRP), is commonly present in persons with metabolic syndrome. 
It is related to obesity, because excess adipose tissue releases 
inflammatory cytokines causing elevated CRP levels.  
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A prothrombotic state - characterized by increased plasma plasminogen 
activator inhibitor (PAI)-1 and fibrinogen, also associates with the 
metabolic syndrome. Thus, prothrombotic and proinflammatory states 
may be metabolically interconnected.  
 
Fig 6 Clustering of various risk factors in metabolic syndrome 
 
 
 
 
Pathogenesis of Metabolic Syndrome 
a)  Obesity and Abnormal Body Fat Distribution 
Obesity contributes to hypertension, dyslipidemia and 
hyperglycemia. Abdominal obesity especially correlates with metabolic 
risk factors. Excess adipose tissue releases several products like 
nonesterified fatty acids (NEFA), cytokines, PAI-1 and adiponectin 
which overload muscle and liver with lipid, thereby enhancing insulin 
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resistance. High CRP levels and low adiponectin levels accompanying 
obesity may signify a proinflammatory state. An elevated PAI-1 
contributes to a prothrombotic state.  
Fig 7 
 
   HSL-hormone sensitive lipase; LPL- lipoprotein lipase, TG-triglyceride and  
   VLDL-very low density lipoprotein. 
 
 
b)  Insulin resistance 
c)  Other Contributing Factors – 
1)  Advancing age - The prevalence of metabolic syndrome increases 
with age, affecting less than 10 percent of people in  their 20s and  
      40 percent of people in their 60s20. 
2)  Race - Hispanics and Asians seem to be at greater risk for metabolic 
syndrome than other races. 
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3)  Elevated C - Reactive protein- Obesity and the metabolic syndrome 
are associated with elevated levels of CRP, suggesting a strong 
relationship between the metabolic derangement and inflammation. 
Studies have shown that elevated CRP increased progressively from 
1.9 for those with one risk factor to 6.8 when all five of the ATP III 
criteria were present.  
4)  Plasminogen activator inhibitor-1 (PAI-1) is a protein released into 
the circulation from endothelial cells that inhibits tissue-type 
plasminogen activator (t-PA) which in turn leads to decreased 
plasmin (fibrinolysin) and ultimately, to increased levels of 
circulating fibrinogen. Both PAI-1 and fibrinogen correlate with 
levels of insulin and its precursors. The analysis of PAI-1 is not 
performed in most clinical laboratories21.  
5) Microalbuminuria- an early indicator of nephropathy in both 
diabetic and hypertensive individuals and regarding metabolic 
syndrome, the WHO recommendation of > 20µg/min for timed 
collections is in accordance with the definition of microalbuminuria22. 
6)  Uric acid has been shown to be a powerful risk marker for CVD. 
7)  Serum gamma - glutamyl transpeptidase, fibrinogen, factor - 
VIII: c, cytokines IL-6 & 10, TNF-α, adhesion molecules ICAM 1 
& VCAM 1. 
8)  Fasting homocysteine levels. 
22
 
   
 
 
 
 
  
  
 
Fig 8 Pathogenesis of Cerebro- / Cardio vascular events in 
Metabolic Syndrome 
 
 
 
&  
CEREBROVASCULAR  
EVENTS 
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Criteria for Clinical Diagnosis of Metabolic Syndrome  
a) EGIR 
European Group for the Study of Insulin Resistance (EGIR) (1999) 
requires insulin resistance defined as the top 25% of the fasting insulin 
values among non-diabetic individuals AND two or more of the 
following: 
• central obesity: waist circumference  ≥ 94 cm (male),  
≥ 80 cm (female)  
• dyslipidemia: TG ≥ 2.0 mmol/L and/or  
   HDL-C < 1.0 mg/dL or treated for dyslipidemia  
• hypertension: blood pressure ≥ 140/90 mmHg or  
antihypertensive medication  
• fasting plasma glucose ≥ 6.1 mmol/L  
 
b) NCEP ATP III14 
The National Cholesterol Education Program Adult Treatment 
Panel III (2001) requires at least three of the following:  
Risk Factor 
 
Defining Level 
 
1.  Abdominal obesity, given as waist 
circumference 
 
     Men >102 cm (>40 in) 
     Women >88 cm (>35 in) 
 
2. Triglycerides 
 
150 mg/dL 
24 
 
   
 
 
 
 
  
  
 
3. HDL cholesterol  
     Men                                                       <40 mg/dL 
     Women <50 mg/dl 
 
4. Blood pressure 130/ 85 mm Hg 
 
5. Fasting glucose 110 mg/dL  
 
 
 Waist circumference is measured at the midpoint 
between the lower border of the rib cage and the iliac crest. 
It is simpler to measure, culturally more acceptable to our 
population and is a better indicator of central obesity 
compared to WHR23. 
 
 The American Diabetes Association has recently 
established a cutoff point of 100 mg/dL, above which 
persons have either prediabetes (impaired fasting glucose) 
or diabetes. This new cutpoint should be applicable for 
identifying the lower boundary to define an elevated 
glucose as one criterion for the metabolic syndrome. 
  
 
c) World Health Organization 
In 1998, a World Health Organization (WHO) consultation group 
outlined a working definition of the metabolic syndrome24. A potential 
disadvantage is the need for special testing of glucose status beyond 
routine clinical assessment. 
Advantages: 
i)   Each component of the syndrome conveys increased cardiovascular 
risk, but as a combination they become much more powerful. 
 
   
 
 
 
 
  
  
 
ii)   The features of metabolic syndrome may be present for up to 10 years 
before detection of glycaemic disorders. 
Insulin resistance, identified by one of the following: 
    • Type 2 diabetes 
    • Impaired fasting glucose 
    • Impaired glucose tolerance 
    Plus any 2 of the following: 
    • Antihypertensive medication and/or high blood pressure ( 140 mm 
       Hg systolic or 90 mm Hg diastolic) 
    • Plasma triglycerides 150 mg/dL ( 1.7 mmol/L) 
    • HDL cholesterol <35 mg/dL (<0.9 mmol/L) in men or <39 mg/dL 
       (1.0 mmol/L) in women 
    • BMI >30 kg/m2 & /or waist: hip ratio >0.9 in men, >0.85 in women 
    • Urinary albumin excretion rate 20 µg/min or 
       albumin:creatinine ratio 30 mg/g. 
  
 
D) American Association of Clinical Endocrinologists25 
  These criteria appear to be a hybrid of those of ATP III and WHO 
metabolic syndrome.  
Risk Factor Components  
 Cut points for Abnormality  
 Overweight/obesity BMI 25 kg/m2 
 
 Elevated triglycerides  150 mg/dL (1.69 mmol/L) 
 
 Low HDL cholesterol  
           Men <40 mg/dL (1.04 mmol/L) 
          Women <50 mg/dL (1.29 mmol/L) 
 
 Elevated blood pressure  130/85 mm Hg 
25 
 
   
 
 
 
 
  
  
 
 
 2-Hour post glucose 
challenge 
>140 mg/dL 
 Fasting glucose 110 -126 mg/dL 
 Other risk factors Family history of type 2 diabetes, 
hypertension, or CVD 
 Polycystic ovary syndrome 
 Sedentary lifestyle 
 Advancing age 
 Ethnic groups having high risk for type 
2 diabetes or CVD 
 
 
   
 
E) AHA/NHLBI26 
The American Heart Association and the National Heart, Lung, 
and Blood Institute updated the NCEP ATP III definition & 
recommended that the metabolic syndrome be identified as the presence 
of three or more of these components:  
 Elevated waist circumference:  
          Men — equal to or greater than 40 inches (102 cm)    
          Women —   equal to or greater than 35 inches (88 cm)  
 Elevated triglycerides: Equal to or greater than 150 mg/dL  
 Reduced HDL (“good”) cholesterol:  
      Men — Less than 40 mg/dL;   Women — Less than 50 mg/dL  
 Elevated blood pressure:  > 130/85 mm Hg or use of medication 
26 
 
   
 
 
 
 
  
  
 
for hypertension.  
 Elevated fasting glucose:  > 100 mg/dL (5.6 mmol/L) or use of    
medication for hyperglycemia. 
 
F) International Diabetic Federation (IDF) 27 
It defines metabolic syndrome as the presence of central obesity 
(Waist circumference > 94 cm males ;> 80cm females) + any 2 of the 
following 4 factors: 
Raised triglyceride level (>150 mg/dl),  
Reduced HDL cholesterol (< 40males; <50 females),  
Raised blood pressure (>130/85 mmHg) and 
Raised fasting plasma glucose (>100mg/dl). 
 
Advantage: 
This definition has proposed ethnicity-specific cutoff values for 
waist circumference, namely, 94 and 80 cm for European men and 
women, respectively, and 85 and 90 cm for Japanese men and women, 
respectively.  In contrast, NCEP ATP III criteria, applied to an Asian 
population will underestimate the population at risk. With a lower waist 
circumference cutoff, the prevalence of the metabolic syndrome is 
comparable to that in Western populations28.  
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Metabolic Syndrome Features, Measurement of These Features, and 
Features Included in the Current NCEP ATP III Guidelines  
Metabolic 
Syndrome  
Feature 
Clinical 
Measures Research Measures 
NCEP 
ATP III 
Criteria 
Obesity Waist Displacement techniques Waist 
 Body mass 
index 
Bioelectrical impedance 
DEXA scanning 
 
  CT,MRI  
    
    
    
Insulin Resistance Fasting plasma 
glucose 
Plasma leptin, 
adiponectin, resistin 
Plasma insulin 
Fasting 
plasma 
glucose 
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 Oral glucose 
tolerance 
testing 
HOMA/QUICKI  
     Intravenous glucose 
    tolerance testing 
  Hyperinsulinemic clamp 
 
    
        
 
Hypertension 
 
Systolic and 
diastolic BP 
  
Ambulatory 
BP 
 
Vascular 
compliance/stiffness 
 
Microalbuminuria 
 Angiotensin II  
 Endothelin 
 
Systolic 
and 
diastolic 
BP 
    
    
    
Lipoproteins TG, VLDL Transfer proteins and 
enzyme activity 
TG 
 HDL Cholesterol efflux assays 
ex vivo 
HDL 
 Small dense 
LDL 
Postprandial lipoprotein 
responses 
 
  Lipoprotein turnover 
studies 
 
 
 
 
 
 
 
Inflammation White cell 
count 
Serum amyloid A  NA 
 C-reactive 
protein 
Fibrinogen, factor VIII 
Sialic acid  
Cytokines IL-6, TNF- , 
IL-10 
 
    
    
  Soluble adhesion 
molecules: ICAM-1, 
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VCAM, E-selectin 
 
Prothrombotic, 
fibrinolytic 
  
Evoked inflammatory 
responses 
Plasma PAI-1, D-dimer 
 
 NA 
  Plasma FPA, F1–2  
    
  Urinary 11-dehydroTXB   NA 
 
Oxidant stress 
  
Oxidized LDL 
Isoprostanes 
 
    
Genetics  DNA /protein adducts  NA 
 
 
 Candidate gene single 
nucleotide polymorphism 
MetSyn (SNPs) 
 
 
  Genome-wide scan—
linkage analysis 
 
 
BP-blood pressure, DEXA-dual-energy X-ray absorptiometry  
HOMA-, Homeostasis Model Assessment (HOMA)  
QUICKI- Quantitative Insulin Sensitivity Check Index;  
IL- interleukin, TNF- tumor necrosis factor,  
ICAM, intercellular adhesion molecule, 
VCAM-vascular cellular adhesion molecule  
PAI- plasminogen activator inhibitor and NA- not applicable. 
 
 
Therapeutic Goals and Recommendations for Clinical Management 
of Metabolic Syndrome  
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Therapeutic Target and Goals 
of Therapy 
Therapeutic Recommendations 
 
Lifestyle risk factors  
Long-term prevention of CVD and 
prevention (or treatment) of type 2 
diabetes mellitus  
    Abdominal obesity 
 Weight reduction by 7% - 10% 
during year 1 of therapy and
achieve desirable weight 
 (BMI <25 kg/m2)  
 
Weight maintenance/reduction 
through appropriate balance of 
physical activity, caloric intake, and 
formal behavior-modification 
programs when indicated to 
maintain/achieve waist circumference 
of <40 inches in men and <35 inches 
in women.  
  
    Physical inactivity 
Regular physical activity; at 
least 30 min of moderate-
intensity continuous or 
intermittent at least  5 d/wk 
In patients with established CVD, 
encourage 30 to 60 min of moderate-
intensity aerobic activity: brisk 
walking, preferably daily, 
supplemented by increase in daily 
lifestyle activities (eg, pedometer step 
tracking, walking breaks at work, 
gardening, housework).  Encourage 
resistance training 2 d/wk. Advise 
medically supervised programs for 
high-risk patients (eg, recent acute 
coronary syndrome or 
revascularization, CHF).  
 
  
Atherogenic diet 
Reduced intake of saturated  
fat, transfat, cholesterol  
 
 
Recommendations: saturated fat <7% 
of total calories; reduce trans fat; 
dietary cholesterol <200 mg/dL; total 
fat 25% to 35% of total calories. Most 
dietary fat should be unsaturated; 
simple sugars should be limited.  
 
Metabolic risk factors  
  
Shorter-term prevention of CVD or 
treatment of type 2 diabetes mellitus 
1. Atherogenic dyslipidemia  
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Primary target: ↑ LDL - C  
Secondary target: ↑non-HDL-C 
Reduce LDL-C according to ATP III 
guidelines. 
High-risk patients*: 
 <130 mg/dL (3.4 mmol/L) 
(optional: <100 mg/dL [2.6 
mmol/L] for very high-risk 
patients )    
 Moderately high-risk 
patients : <160 mg/dL (4.1 
mmol/L)     Therapeutic option: 
<130   mg/dL (3.4 mmol/L)  
 Moderate-risk patients : <160 
mg/dL (4.1 mmol/L)       
Lower-risk patients||: <190 
mg/dL (4.9 mmol/L) 
 
Tertiary target: ↓ HDL-C 
 No specific goal: Raise HDL -C 
to extent possible with standard 
therapies 
1)  to achieve non-HDL-C goal: 
Intensify LDL-lowering therapy.  
2)  Add fibrate (preferably
fenofibrate) or nicotinic acid if 
non-HDL-C remains relatively 
high after LDL-lowering drug 
therapy (add fibrate or nicotinic 
acid in high-risk patients) 
3)  All patients: If TG  500 mg/dL,
initiate fibrate or nicotinic acid 
(before LDL-lowering therapy; 
treat non-HDL-C) 
 
 
 Maximize lifestyle therapies:     
 Weight reduction and increased
physical activity. Add fibrate or 
nicotinic acid after LDL-C-lowering  
drug therapy 
 
2. Elevated BP 
Reduce BP to <140/90 mm Hg 
(or <130/80 mm Hg if diabetes 
present).  
Reduce BP further to extent 
possible through lifestyle 
changes.  
 
 
 
 
 
 
 
 
 
3. Elevated glucose 
 
For IFG, delay progression to 
type 2 diabetes mellitus. 
 
For BP 120/80 mm Hg: Initiate or 
maintain lifestyle modification in all 
patients with metabolic syndrome: 
weight control, increased physical 
activity, alcohol moderation, sodium 
reduction, and emphasis on increased 
consumption of fresh fruits, 
vegetables, and low-fat dairy products 
(DASH diet).  
 
For BP 140/90 mm Hg (or 130/80 
mm Hg for individuals with chronic 
kidney disease or diabetes):  
As tolerated, add BP medication (ACE 
inhibitors, ARBs.)  
 
 
 
- For IFG, encourage weight reduction 
and increased physical activity.   
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For diabetes, HbA1C <7.0%  
 
 
 
 
 
- For type 2 diabetes mellitus, lifestyle 
therapy& pharmacotherapy to achieve 
HbA1C (<7%).  Modify other risk 
factors and behaviors.  
4. Prothrombotic state 
Reduce thrombotic and 
fibrinolytic risk factors 
 
High-risk patients: Initiate and 
continue low-dose aspirin therapy; 
-    In patients with ASCVD, consider 
clopidogrel if aspirin is 
contraindicated.    
- Moderately high-risk patients: 
Consider low-dose aspirin prophylaxis 
 
5. Proinflammatory state 
 
Recommendations: no specific 
therapies beyond lifestyle therapies 
*High-risk patients - established ASCVD, diabetes, or 10-year risk for coronary 
heart disease >20%. For cerebrovascular disease, high-risk condition includes TIA or 
stroke of carotid origin or >50% carotid stenosis. 
 
Very high-risk patients - likely to have major CVD events in next few years, and 
diagnosis depends on clinical assessment. Factors that may confer very high risk 
include recent acute coronary syndromes, and established coronary heart disease + 
any of following: multiple major risk factors (especially diabetes), severe and poorly 
controlled risk factors (especially continued cigarette smoking), and metabolic 
syndrome. 
 
Moderately high-risk patients - 10-year risk for CVD10% to 20%. Factors that 
favor therapeutic option of non-HDL-C <100 mg/dL are those that can raise 
individuals to upper range of moderately high risk: multiple major risk factors, 
severe and poorly controlled risk factors (especially continued cigarette smoking), 
metabolic syndrome, and documented advanced subclinical atherosclerotic disease 
(eg, coronary calcium or carotid intimal-medial thickness >75th percentile for age 
and sex). 
Moderate-risk patients - with 2+ major risk factors and 10-year risk <10%.  
||Lower-risk patients are those with 0 or 1 major risk factor and 10-year risk <10%. 
 
Elevated LDL-C: Primary Target of Lipid-Lowering Therapy in 
People at Risk for ASCVD 14 
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Goals of Therapy  Therapeutic Recommendations  
High-risk patients: 
 <100 mg/dL  
 Very high risk 
 patients:<70 mg/dl 
 
Moderately high-risk 
patients: <130 mg/dL 
High risk patients: 
optional goal is <100 
mg/dL (2.6 mmol/L) 
 
 
 
Moderate-risk 
patients: <130 mg/dL 
 
 
Lower-risk patients: 
<160 mg/dL  
   High-risk patients:  
   lifestyle therapies. Add   LDL-C-lowering 
   drug if baseline LDL-C 100 mg/dL 
 
 
   Moderately high-risk patients: lifestyle 
   therapies. Add LDL-lowering drug when 
   LDL-C 130 mg/dL (3.4 mmol/L). 
   If  baseline LDL-C 100- 129 mg/dL, LDL- 
   lowering therapy  introduced if patient’s risk 
   is assessed to be in upper ranges of this risk 
   category. 
  
   Moderate risk patients: lifestyle 
   therapies. Add LDL-C lowering drug  when 
   LDL-C 160 mg/dL (4.1 mmol/L). 
 
   Lower-risk patients: lifestyle   therapies. 
   Add LDL-C lowering drug when LDL-C 
   190 mg/dL after lifestyle therapies. For  
   LDL-C 160 to 189 mg/dL,  LDL-   lowering 
   drug is optional). 
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MATERIALS AND METHODS 
 
 This study was a cross-sectional study, conducted in 100 patients 
consisting of 70 males and 30 females with Cerebrovascular disease 
(Stroke) admitted in General wards at Coimbatore Medical College 
Hospital during the period of one year from August 2006 to August 2007. 
 
The Inclusion criteria were 
1)  Both male and female patients presenting with neuro-radiological 
features of stroke (clinically and CT proven, including major and 
minor stroke). 
The criteria used in the clinical diagnosis of stroke were those 
setforth by the Adhoc Committee of National Institute of Neurological 
diseases and blindness. 
The clinical diagnosis was made by  
a)  eliciting a detailed history from the patient or from their relatives, 
regarding the nature of illness with special emphasis on the 
following: 
i)  mode of onset – sudden or gradual 
ii)  time of onset – during early morning hours soon after getting up or 
during day time activities. 
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iii)  associated symptoms – headache, vomiting, convulsion, past history 
of Transient Ischemic attack (TIA), Diabetes mellitus, Ischemic 
heart disease, personal habits like cigarette smoking and alcohol 
drinking in both sexes and intake of oral contraceptive pills in the 
past in females. 
b)   Physical examination which included 
i)  General examination with special regards to obesity, carotid and 
peripheral pulsation, blood pressure, polycythemia, dehydration as 
predisposing factors and acanthosis nigricans as a marker of hyper 
insulinemia. 
ii)  Central nervous system examination for evidence of 
unconsciousness, hemiplegia or paresis, cranial nerve dysfunction, 
speech disturbance, sensory deficits, meningeal and cerebellar 
involvement and optic fundus examination. 
iii)  Cardio vascular respiratory and abdominal examination. 
 In all these patients, clinical diagnosis was confirmed by CT scan of 
the brain for designation of stroke as 
a) Ischemic -   patients with cerebrovascular thrombosis 
b) Hemorrhagic – patients with cerebral hemorrhage 
c) Unclassified – patients who were CT wise normal but had clinical 
evidence of stroke i.e. patients with minor stroke (Transient 
Ischemic Attack (TIA), Reversible Ischemic Neurological Deficit & 
Brain Stem stroke). 
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When there was suspicion of tumor or other etiology, the diagnosis 
was confirmed by  MRI scan, Carotid Doppler, four vessel angiogram to 
rule out embolism,  serum VDRL for syphilis, blood examination for 
anemia, renal failure, polycythemia, coagulation profile to rule out 
bleeding/coagulation defects as cause of cerebral hemorrhage.  ECG, X-
ray Chest and ECHO were done in relevant cases to rule out 
cardiovascular etiology. 
2)  The patients with age ranging from 30 years to 90 years were 
divided into 3 groups:   
 a) up to 40 years (≤ 40 years) 
        b) 41- 59 years 
        c)  ≥ 60 years. 
3)  Patients presenting at the time of data collection. 
The exlusion criteria were 
i)  patients with age less than 30 years. 
ii)  patients with embolic stroke, as there are no significant changes in 
the lipid profile in them. 
iii)  neurological deficit not fitting into above clinical /radiological 
criteria for cerebrovascular disease. 
 They were then subjected to a battery of tests that define metabolic 
syndrome according to one proposed by American Heart Association and 
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the National Heart Lung and Blood Institute, a modification of NCEP 
ACP- III definition.  This definition was chosen as  
a)  it is clinically applicable in Indian context 
b)  relatively easy to perform, cost effective & 
c)  it specifies lower cut off points for waist circumference in Asians 
{males ≥ 90 cm (35 inches), females ≥ 80 cm (31 inches) }as 
compared to ≥ 102 cm in males and ≥ 88 cm in females respectively 
taken in ATP III criteria for metabolic syndrome. 
These tests were – 
i) Fasting Blood Glucose (FBG) ≥ 100 mg/dl or drug treatment for 
elevated glucose. It was measured by oxidase - peroxidase method. 
This test is specific, reproducible, sensitive and rapid. 
Principle: 
D-glucose+H2O+O2      Æ D-gluconic acid +H2O2 
H2O2 + reduced O-Dianisidine   Æ oxidized  
(colorless)                              O-Dianisidine (Brown) 
O-Dianisidine (Brown) H2SO4Æ oxidized O-Dianisidine (Pink) 
The intensity of pink color measured at 540 nm is proportional to 
the original glucose concentration. 
 
ii) Triglyceride:  ≥ 150 mg/dl in both sexes were taken as fulfilling 
criteria for metabolic syndrome. It was measured by enzymatic method 
(Foster and Dunn) Hantzsh reaction. 
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Principle: 
In this reaction, triglycerides are extracted by Haptane and 
saponified by potassium hydroxide. The glycerol is oxidized to 
formaldehyde which combines with acelylacetone in the presence of 
ammonium ions to give dihydrobutidine derivative which is measured 
calorimetrically at 415 nm. 
 
iii) High density lipoprotein (HDL) cholesterol (Lopes and Virella)  
    < 50 mg/dl in females and < 40 mg /dl in males. 
In this procedure, VLDL, Chylomicrons and LDL were 
precipitated by phosphotungstate in the presence of magnesium ions and 
the HDL cholesterol was estimated from the supernatant.  All 
measurements were taken using highly sophisticated modular system of 
Boheinger Knoll, West Germany. 
           For both these tests, blood was withdrawn in the morning before 
breakfast after a minimum of 7 hours of fasting and collected in tubes 
without anticoagulant. Though fasting is not required for estimation of 
HDL cholesterol, as levels drop only slightly after fatty meal, it is 
important for estimation of exogenous lipids like chylomicrons and 
triglycerides. 
              In patients with concomitant acute myocardial infarction, lipid 
profile was done after 3 months as until such time the cholesterol level 
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may be lower than usual.  In the case of patients with cerebral 
thrombosis, blood samples were taken 7 days after development of the 
neurological deficit.  For patients with cerebral hemorrhage, blood 
samples were taken on the day of admission due to bad prognosis 
associated with them. 
 
iv) Waist Circumference:  males ≥ 90 cm (35 inches) 
                                 females ≥ 80 cm (31 inches) 
 
             It was measured halfway between highest level of iliac crest and 
lower rib margin during minimal inspiration. 
 
v) Blood Pressure - Systolic ≥ 130 mmHg and  
Diastolic ≥ 85 mmHg or antihypertensive drug 
therapy in a patient with history of hypertension. 
 
For this, 3 Blood Pressure readings were taken at 2 minute intervals 
in lying posture and highest value was taken into consideration, using a 
standard Sphygmomanometer. 
Presences of any 3 of the above factors constitute the syndrome.   
Analysis was based on determining prevalence of metabolic syndrome in 
stroke patients and studying individual parameters in causation of stroke 
and assessing their percentage attributability to stroke. 
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OBSERVATION AND RESULTS 
 
Chart1: Stroke pattern in100 patients   
 
 Out of 100 Stroke patients studied, 80% (80 patients) had Ischemic 
Stroke and 12% (12 patients) had Hemorrhage stroke. Remaining 8% (8 
patients) were under Unclassified category i.e. clinically diagnosed as 
cerebrovascular disease but CT Brain reported normal. (Patients with 
Transient Ischemic Attack (TIA) /Reversible Ischemic Neurological 
Deficits (RIND) and cases of probable Brainstem stroke where CT Brain      
                       
  
Chart 2: Gender wise distribution of Stroke Pattern: 
 Out of 70 male stroke patients, 53 (76%) had Thrombotic stroke, 
11 (16%) had cerebral hemorrhage and remaining 6 (8%) were under 
unclassified category. 
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 Similarly in 30 female stroke patients, 27 (90%) had Thrombosis,  
1 (3%) had hemorrhage and remaining 2 (7%) were under unclassified 
category. 
 
 
Chart 3: Territory Distribution in Stroke patients 
 
ACA – Anterior Cerebral Artery,  
MCA –Middle Cerebral Artery and  
PCA – Posterior Cerebral Artery 
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  Most common arterial territory involved in our study was Middle 
Cerebral artery, both in Thrombotic (85%) and Hemorrhagic (83.3%) 
patients followed by Posterior Cerebral artery (Thrombosis 11.3%; 
Hemorrhage 16.7%). Anterior Cerebral artery was not involved in 
hemorrhagic infarct. 
 
Table1: Gender in relation to stroke pattern and arterial territory 
involved 
Territory Males Females 
Infarct Left Right Bilateral Total Left Right Bilateral Total 
Grand 
Total 
MCA 27 16 2 45 16 6 1 23 68 
PCA 3 3 1 7 1 1 - 2 9 
ACA - 1 - 1 1 - 1 2 3 
Unclassified    6    2 8 
Subtotal 30 20 3 59 18 7 2 29 88 
Hemorrhage          
MCA 3 7 - 10 - - - - 10 
PCA 1 - - 1 1 - - 1 2 
ACA - - - - - - - - - 
Subtotal 4 7 - 11 1 - - 1 12 
Total Patients    70    30 100 
 
• Most common arterial territory involved in both sexes with 
Ischemic stroke was Left Middle Cerebral artery (Male – 76.3%, 
Female 79.3%) 
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• In males with hemorrhage stroke, out of 11 patients, 10 had 
involvement of MCA territory and 1 had involvement of Posterior 
cerebral artery. 
• Only one female had hemorrhage involving Left Posterior 
territory. 
 
 
Chart 4: Occupation and Stroke 
 
 
 Out of 30 female stroke patients, sedentary life style contributed 
maximum (66.7%) to stroke whereas in 70 males, manual labourers 
(42.9%) had the maximum   stroke incidence.  Sedentary life style was 
associated with stroke risk only in 11 males (15.7%). 
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Fig – 5 CT BRAIN - PLAIN 
LEFT FRONTO – PARIETO - TEMPORAL ISCHAEMIC INFARCT  
 
 
 
 
 
Fig – 6  CT BRAIN - PLAIN 
LEFT  PARIETO - TEMPORAL HEMORRHAGIC INFARCT WITH  
VENTRICULAR EXTENSION 
 
 
          
 
   
 
 
 
 
  
  
 
Table 2: Occupation & Gender in relation to Stroke pattern 
Stroke Males Females Total
 Seden- 
tary 
Moderate 
activity 
Manual 
Labourer Total 
Sedent
ary 
Moderate 
activity 
Manual 
Labourer Total  
Ischemic 
Stroke 7 23 23 53 19 2 6 27 80 
Hemorrhage 
 2 4 5 11 0 1 - 1 12 
Unclassified 2 2 2 6 1 - 1 2 8  
Total 11 29 30 70 20 3 7 30 100 
 
 Cerebral hemorrhage was more common in Moderate activity 
workers and Manual labourers and least common in individuals leading 
sedentary life style. In 20 out of 30 females in our study, who lead 
sedentary life style, none had hemorrhage. 
 
Table 3: Age wise and Gender wise stroke distribution 
Age Males Females 
≤ 40 years  9   (12.(%) Nil 
41-59 years 32 (45.7%)   8   (26.7%) 
≥60 years 39 (55.7%) 22 (73.3%) 
 
The most common age group affected by stroke in males was ≥ 60 
years (55.7%) followed by 41-59 years (45.7%) whereas in females it 
was ≥ 60 years (73.3%) 
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Table 4: Other Risk factors 
 Males Female Total 
 1.  Smoking 51 Nil 51/70 
 2.  Alcohol 51 Nil 51/70 
 3.  IHD 26/70 
(37.1%) 9/30 (30%) 35/100 
 4.  HTN 
 (BP≥140/90mm Hg) 
54/70 
(77.1%) 24/30 (80%) 78/100 
 5. DM  (FBG≥ 126 
mg/dl) 
12/70 
(17.1%) 8/30 (26.7%) 20/100 
 6.  Recurrent Stroke 5/70 (7.1%) 2/30 (6.7%) 7/100 
 7.  Mean HDL (mg/dl) 38.6 ± 1.6 39 ± 2.9 - 
 8.  Mean TGL  (mg/dl) 140.6 ± 7 147 ± 9.8 - 
 9.  Mean FBG  (mg/dl)    111.5 ± 9.5 120 ± 18.8 - 
10. Mean WC (inches) 31 ± 1.1 30 ± 1.4 - 
11. Mean BP (mmHg) 153 ± 6.5/ 95 
± 4.5 
156 ±10.2/ 90 
±5.8 - 
12. Mean age (years) 
13. TGL / HDL 
56 ± 3 
3.84 ± 0.3 
63 ± 4.2 
3.89 ± 0.4 
- 
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Table 5: Age-wise distribution of various Metabolic Parameters in 
both Sexes 
Table 5(i):  Age-wise distribution of Fasting blood glucose (FBG) in 
both Sexes 
 Males Females 
Age No. 
Mean 
FBG 
(mg /dl) 
No. 
with 
FBG  
 ≥ 100 
mg/dl 
% No.
Mean 
FBG 
(mg /dl) 
No. 
with 
FBG 
≥ 100 
mg/dl 
% 
≤ 40 
years 9 119.2 8 88.9 - -- - Nil 
41-59 
years 32 112 13 40.6 8 105 5 62.5
≥60 
years 29 108.4 16 55.2 22 128 14 63.6
  
Irrespective of sex, all the age groups had Mean Fasting blood 
glucose ≥100 mg/dl.   Out of 70 males and 30 females, 37 males and 19 
females respectively had Fasting blood glucose ≥100 mg/dl. In males, the 
criterion of FBG for metabolic syndrome was most commonly fulfilled 
by age group ≤ 40 years (88.9%), whereas in females, > 40 years (63%) 
group fulfilled the criteria.  
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Table 5 (ii): Age-wise distribution of HDL Cholesterol (HDL) in   
 both sexes 
 Males Females 
Age No. 
Mean 
HDL 
(mg /dl)
No. 
with 
HDL 
<40 
mg/dl 
% No. 
Mean 
HDL 
(mg /dl) 
No. 
with 
HDL 
<50 
mg/dl 
% 
≤ 40 
years 9 39.8 2 22.2 - -- - Nil 
41-59 
years 32 39.4 13 40.6 8 40 8 100
≥60 
years 29 37.2 18 62.1 22 39.2 21 95 
 
Out of 70 males, 33 had HDL < 40 mg/dl. Most common age group 
affected by HDL parameter was ≥60 years (62.1%). In all the age 
groups, HDL was more or less the same, implying that it had not 
contributed in a major way for the metabolic syndrome.  
 
 Out of 30 females, 29 had HDL < 50 mg/dl. All females in the age 
group 41-59 years fulfilled the criteria for metabolic syndrome through 
impaired HDL levels (<50 mg/dl) followed closely by age group ≥60 
years.  Irrespective of age group, females were at risk of metabolic 
syndrome due to impaired HDL levels (<50 mg/dl).  It was also observed 
in all females that HDL was much lower than the desired level of 50 
mg/dl.  
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Table 5 (iii): Age-wise Distribution of Triglyceride (TGL) in both 
sexes 
 Males Females 
Age No. 
Mean 
TGL 
(mg /dl) 
No. 
with 
TGL 
≥ 150 
mg/dl
% No.
Mean 
TGL 
(mg /dl)
No. 
with 
TGL 
≥ 150 
mg/dl 
% 
≤ 40 
years 9 144.7 3 33.3 - - - - 
41-59 
years 32 144.3 13 40.6 8 148 2 25 
≥60 
years 29 135.2 8 27.6 22 147 10 45.5 
 
Out of 70 males, 24 had TGL ≥ 150 mg/dl.  In all age groups, 
males had mean TGL level in the normal desired range (<150 mg/dl).  
Most common age group in which Triglyceride level fulfilled the criteria 
for metabolic syndrome was 41-59 years. (40.6%). 
 
Out of 30 females, 12 had TGL ≥ 150 mg/dl.  All age-groups of 
females had mean TGL level in the normal desired range (<150 mg/dl).  
However, females in the age group ≥ 60 years (45.5%) had high TGL 
levels (≥ 150 mg/dl) thereby fulfilling the criteria for metabolic 
syndrome. 
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Table 5 (iv): Age-wise Distribution of Waist Circumference (WC) in 
both sexes   
 Males Females 
Age No. Mean WC(inches) 
No. 
with 
WC ≥ 
35 
inches 
% No. Mean WC (inches) 
No. 
with 
WC 
≥ 35 
inches 
% 
≤ 40 
years 9 31.41 2 
22.
2 - -- - Nil
41-
59 
years 
32 31 9 28.1 8 31 3 
37.
5 
≥60 
years 29 30.9 8 
27.
6 22 30 10 
45.
5 
  
In all age groups, males had Mean Waist Circumference in the 
normal range of < 35 inches; whereas Females in the age group 41-59 
years had Mean Waist Circumference of 31 inches. Males in the age 
group > 41-59 years (28.1%) and   > 60 years (27.6%) and Females in 
the age group ≥ 60 years (45.5%) contributed most to the syndrome 
through the waist circumference parameter. 
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Table 5 (v): Age-wise distribution of Blood Pressure (BP) in both sexes 
 Males Females 
Age No. Mean BP (mmHg) 
No. 
with 
BP ≥ 
130/85 
mmHg 
% No. Mean BP (mmHg) 
No. 
with 
BP ≥ 
130/85 
mmHg 
% 
≤ 40 
years 9 
156.2/ 
90.8 6 66.7 - -- - Nil 
41-59 
years 32 
150.2/ 
93.1 23 71.9 8 158 / 99 7 87.5 
≥60 
years 29 
169.4/ 
98.3 26 89.7 22 158 / 96 18 81.8 
 
Irrespective of age and sex, all had mean BP in the hypertensive 
range according to Stage I of JNC VII (140-159 / 90-99 mm Hg).  Out of 
70 males, 55 had BP ≥ 130/85 mm Hg and the most affected were in the 
age group ≥ 60 years (89.7%) 
 
Out of 30 females > 40 years, 25 had metabolic syndrome due to BP 
criteria of >130 / 85 mmHg. 
 
Table 6: Prevalence of Metabolic Syndrome in Stroke Patients 
Sex Number of Patients 
Number of 
Metabolic 
Patients 
% 
Male 70 31 44.3 
Female 30 22 73.3 
 
 
 
 
52 
 
   
 
 
 
 
  
  
 
Chart 7 - Prevalence of Metabolic syndrome in  Stroke Patients 
 
Out of 100 stroke patients under the present study, 53 (31 males and 
22 females) fulfilled the criteria for metabolic syndrome. 
  
Chart 9 - Prevalence of Metabolic syndrome in Males (n=70) 
 
 
 
Metabolic, 31, 44%
Nonmetabolic, 
39, 56% 
 
Metabolic, 53% Nonmetabolic, 
47% 
 
 
 
Out of the 70 male patients, 31 patients had metabolic syndrome and   
39 were non –metabolic. 
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      Out of the 30 females, 22 had metabolic syndrome and 8 were 
non-metabolic. 
 
Table 7: Metabolic Syndrome and Type of stroke 
Type of 
Stroke 
Male 
Metabolic  
n=31 
Female 
Metabolic 
n=22 
Total 
n=53 
Ischemic 23 20 43 
Hemorrhage 7 1 8 
Unclassified 1 1 2 
 
In both sexes with metabolic syndrome, Ischemic stroke was the 
most Common stroke type observed (43 patients i.e. 81%). 
Chart 9 - Prevalence of Metabolic syndrome in Females (n=30) 
 
 
Metabolic, 22, 
73% 
Nonmetabolic, 
8, 27% 
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Chart10: Percentage Contribution of each metabolic parameter to 
Metabolic syndrome in both Sexes. 
No. of males-70, females-30 
 
FBG - Fasting Blood Glucose  
HDL- High Density Lipo protein   
TGL – Triglyceride 
BP- Blood Pressure,  
WC - Waist Circumference 
• 19 (63%) females and 37(53%) males had FBG ≥ 100 mg/dl that 
fulfilled the syndrome defining criteria. (Overall contribution of 
56% by FBG to the syndrome.) 
• 29 (97%) females and 33 (47%) males contributed to the syndrome 
due to abnormal HDL levels. 
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• 12 (40%) females and 24 (34%) males had abnormal TGL levels (≥ 
150 mg/dl). 
• 13 (43%) females and 19 (20%) males fulfilled the criteria by 
having abnormal waist circumference. 
• Abnormal BP (≥ 130/85) as the metabolic parameter was observed 
in 25 (82%) females and 55 (76%) males. 
 
Chart 11:  Percentage Contribution of each metabolic parameter in 
100 stroke patients 
 
FBG - Fasting Blood Glucose  
HDL-High Density Lipo protein   
TGL – Triglyceride 
BP- Blood Pressure,  
WC - Waist Circumference 
 
Most common parameter that contributed the maximum to 
Metabolic syndrome was Blood Pressure (80%). 
BP, 80% 
WC, 32%
TGL, 36%
HDL, 62%
FBG, 56%
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Chart 12:  Percentage Contribution of each metabolic parameter in 
53 metabolic syndrome patients 
 
 
 
FBG - Fasting Blood Glucose  
HDL-High Density Lipo protein   
TGL – Triglyceride,  
WC - Waist Circumference 
BP- Blood Pressure 
 
Most common parameter that contributed the maximum to 
Metabolic syndrome was Blood Pressure (90.6%). 
 
 
 
 
FBG, 77.4% 
HDL, 84.9% 
TGL, 58.5%
WC, 56.6% 
BP, 90.6%
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 Table 8: Metabolic syndrome and age in both sexes 
Age 
(years) 
Female 
Patients 
No. of 
Metabolic 
female  
patients 
% Male  Patients
No. of 
Metabolic 
male  
patients 
% 
≤ 40 -- -- -- 9 3 33.3 
41-59 8 5 62.5% 32 14 43.8 
≥ 60 22 17 77.3% 29 14 48.3 
 
In females, most common age group affected by Metabolic 
syndrome was ≥ 60 years (77.3%) whereas in males 43.8 % of 41-59 
years group and 48.3% of ≥ had larger number of metabolic syndrome 
patients.  
 
Overall, metabolic syndrome was more prevalent in females                 
(> 40 years) than in males. 
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Chart 13: Distribution of Various Parameters in Male Metabolic 
syndrome Patients (N=31) 
 
FBG - Fasting Blood Glucose  
HDL-High Density Lipo protein   
TGL – Triglyceride,  
WC - Waist Circumference 
BP- Blood Pressure 
 
Out of the total 31 Metabolic Syndrome male patients, 15 (48.4%) 
patients were with 3 parameters, 12 (38.7%) were with 4 parameters and 
4 (12.9%) were with all 5 parameters. 
 
FBG/HDL/BP, 4 
FBG/WC/BP, 3
HDL/TGL/BP, 3
FBG/HDL/TGL/BP, 5 
FBG/HDL/WC/BP, 3
HDL/TGL/WC/BP, 2
FBG/HDL/TGL/WC/BP, 4 
FBG/WC/TGL/BP, 2  
FBG/HDL/TGL, 2
HDL/WC/BP, 1 
TGL/WC/BP, 2 
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Chart 14: Distribution of Various Parameters in Female Metabolic 
syndrome Patients (N=22) 
 
FBG - Fasting Blood Glucose  
HDL-High Density Lipo protein   
TGL – Triglyceride,  
WC - Waist Circumference 
BP- Blood Pressure 
 
Out of the total 22 Metabolic Syndrome female patients, 8 (36.4%) 
patients were with 3 parameters -11 (50%) were with 4 parameters and 3 
(13.6%) were with all 5 parameters.  
 
HDL/TGL/WC, 1 
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Table 9: Smoking and Metabolic syndrome 
 Smoking 
Non-
smoking 
 
Total 
Metabolic  
syndrome 19 12 
31 
 
 
Non Metabolic 32 7 39  
Total 51 19 70 
 
        None of the females in our study had the habit of smoking. Out of 
the 51 smokers in males, 19 (37%) had metabolic syndrome. Out of the 
19 nonsmokers, 12 (63.2%) had metabolic syndrome. 
                 
Table 10: Alcohol and Metabolic syndrome in males                                                   
 Alcoholic Non-alcoholic Total 
Metabolic  
syndrome        23 8 
31 
 
 
Non Metabolic 29 10 39  
Total 52 18 70 
                                                                 
 None of the females under our study were alcoholic. Of the 70 
males, 52 were alcoholic and within them 23(44%) had metabolic 
syndrome. Of the 18 nonalcoholic males, 8 (44%) had metabolic 
syndrome. 
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Chart 15: Diabetes Mellitus and Metabolic syndrome (N=53 ) 
  
Out of 53 metabolic syndrome patients, 15(28.3%) were diabetics 
& 36 (67.9%) were prediabetics. 
 
Table 11: Distribution of Diabetes and Prediabetes in  
 Metabolic syndrome population 
Diabetic- FBG >126 mg /dl 
Prediabetic (impaired fasting glucose) - FBG 100 -125 mg /dl 
 Males Females 
 Diabetic Prediabetic Diabetic Prediabetic 
Metabolic 7 / 31 16 / 31 8  / 22 10 / 22 
Nonmetabolic 5 / 39 9 /  39 Nil 1 / 8 
Total 12 / 70 25  / 70 8 / 30 11 / 30 
  
Out of 70 male stroke patients, 12 (17.1%) were diabetic and 25 
(35.7%) were prediabetic. Out of 31 male metabolics, 7 (22.6%) were 
diabetic and 16 (51.6%) were prediabetic.  
 
Prediabetic, 36, 67.9%
Nondiabetic, 2, 3.8% Diabetic, 15, 
28.3% 
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Out of the 12 diabetic males, 7 (58.3%) had metabolic syndrome 
and out of 25 prediabetic males, 16 (51.6%) had metabolic syndrome.  
 
Of the 30 female stroke patients, 8 (26.7%) were diabetic and 11 
(36.7%) were prediabetic.  Out of 22 female metabolic, 8 (36.4%) were 
diabetic and 10 (45.5%) were prediabetic. While all 8 diabetic women 
had metabolic syndrome, only 10 (91%) out of 11prediabetic women, 
had metabolic syndrome.  
 
Table 12: Hypertension and Metabolic syndrome  
Hypertension - (≥ 140 /90 mm Hg- Stage I according to JNC VII) 
Prehypertension- (Systolic 121-139 mmHg and Diastolic 81-89 mm Hg)   
 Males Females 
 Hypertensive Prehypertensive Hyper-tensive 
Prehyper-
tensive 
Metabolic 29 / 31 -- 19 / 22 1 / 22 
Nonmetabolic 25 / 39 7 / 39 5 / 8 1 / 8 
Total 54 / 70 7 / 70 24 / 30 2 / 30 
 
Out of 70 male stroke patients, 54 (77.1%) were Hypertensive and 
7 (10%) were Prehypertensive. Out of 30 female stroke patients, 24 
(80%) were Hypertensive and 2 (6.7%) were Prehypertensive. Out of the 
total 53 metabolic syndrome patients, 48 (29 males and 19 females) 
(90.6%) were hypertensive.  
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Out of 31 male metabolics, 29 (93.5%) were Hypertensive and 
none were Prehypertensive. Out of 22 female metabolics, 19 (86.4%) 
were Hypertensive and 1 (4.5%) was Prehypertensive. 
  
Out of 54 hypertensive males, 29 (53.7%) had metabolic 
syndrome. Out of 24 hypertensive females, 19 (79.2%) had metabolic 
syndrome and out of 2 Prehypertensive females, 1 (50%) had metabolic 
syndrome. 
 
Chart 16: Both Hypertension and Diabetes in combination with 
Metabolic syndrome 
a) N=100 stroke patients 
 
Out of 100 stroke patients under our study, 19 had both Diabetes and 
Hypertension. 
 
  
 59 19 1
21 NON DIABETIC AND NON HYPERTENSIVE 
HYPERTENSIVE 
DIABETIC 
BOTH HYPERTENSIVE 
AND DIABETIC 
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b) N=53 metabolic syndrome patients 
 
Out of 53 metabolic syndrome patients, 14 (26.4%) had both 
hypertension and diabetes. 
Table 13: HDL Cholesterol and Metabolic Syndrome 
 Males Females 
 No. with 
HDL<40  
mg / dl 
No. with 
HDL>40  
mg / dl 
No. with 
HDL<50  
mg / dl 
No. with 
HDL> 50 
mg / dl 
Metabolic 24 / 31 7 / 31 21 /22 1 / 22 
Nonmetabolic 9 / 39 30 / 39 8 / 8 Nil 
Total 33 / 70 37 / 70 29 / 30 1 / 30 
 
Out of 31 male metabolics, 24 (77.4%) had HDL<40 mg / dl. Out 
of 30 female stroke patients, 29(96.7%) had HDL< 50 mg / dl and 
remaining 1(3.3%) had HDL in the normal range. Out of these 29 
females with HDL< 50 mg / dl, 21(72.4%) had metabolic syndrome.  
Out of 22 female metabolics, 21 (95.5%) had HDL< 50 mg / dl and all 
the 8 non-metabolic patients had HDL< 50 mg / dl. 
 
  
 34 14 1
4 NON DIABETIC AND NON HYPERTENSIVE 
HYPERTENSIVE 
DIABETIC 
BOTH HYPERTENSIVE 
AND DIABETIC 
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Table 14: Triglyceride (TGL) and Metabolic Syndrome 
 Males Females 
 No. with 
TGL>150 
mg / dl 
No. with 
TGL<150 
mg / dl 
No. with 
TGL>150 
mg / dl 
No. with 
TGL<150 mg 
/ dl 
Metabolic 20 / 31 11 / 31 11 /22 11 / 22 
Nonmetabolic 4 / 39 35 / 39 1/ 8 7 / 8 
Total 24 / 70 46 / 70 12 / 30 18 / 30 
 
Out of 70 male stroke patients, 24 (34.31%) had TGL>150 mg / dl 
and remaining 46 (65.7%) had TGL in the normal range. Out of 24 males 
with TGL>150 mg / dl, 20 (83.3%) had metabolic syndrome and out of 
46 males with normal TGL (<150 mg / dl), only 11 (23.9%) had 
metabolic syndrome. Out of 31 male metabolics, 20 (64.5%) had 
TGL>150 mg / dl. 
 
Out of 30 female stroke patients, 12 (40%) had TGL>150 mg / dl 
and remaining 18 (60%) had TGL in the normal range. Out of these 12 
females with TGL>150 mg / dl, 11(91.7%) and out of 18 females with 
normal TGL (<150 mg / dl), 11 (61%) had metabolic syndrome. Out of 
22 female metabolics, 11 (50%) had TGL>150 mg / dl. 
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Table 15:  Waist circumference (WC) and Metabolic Syndrome 
 
 Males Females 
 No. with 
WC 
>35 inches 
No. with 
WC 
< 35 inches
No. with 
WC 
> 31inches 
No. with 
WC 
< 31inches 
Metabolic 17 / 31 14 / 31 13 /22 9 / 22 
Nonmetabolic 2 / 39 37 / 39 Nil 8 / 8 
Total 19 / 70 51 / 70 13 / 30 17 / 30 
 
Out of 70 male stroke patients, 19(27%) had WC>35 inches and 
remaining 51(72.9%) had WC<35 inches. Out of 19 males with WC>35 
inches, 17 (89.5%) had metabolic syndrome and out of 51 males with 
WC<35 inches, only 14 (27.5%) had metabolic syndrome. Out of 31 
male metabolics, 17 (54.8%) had WC >35 inches. 
 
Out of 30 female stroke patients, 13 (43.3%) had WC> 31inches 
and remaining 17 (56.7%) had WC< 31inches. Out of these 13 females 
with WC> 31inches, all 13 (100%) and out of 17 females with WC< 
31inches, 9 (52.9%) had metabolic syndrome. Out of 22 female 
metabolics, 13 (59.1%) had WC> 31 inches. All non metabolic females 
had normal waist circumference.  
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DISCUSSION 
Lipid profile & Stroke 
In a case control study conducted on 76 patients, with an age range 
of 40-70 years by Immanuel Sin35, consisting of  38 post ischemic stroke 
patients and 38 controls, HDL levels were significantly lower in stroke 
patients as compared to control subjects (p<0.05). The study concluded 
that low HDL-cholesterol level is a risk factor for ischemic stroke, with 
an odds ratio of 3.09, while total cholesterol, triglyceride and high LDL- 
cholesterol levels were not risk factors for ischemic stroke. 
 
In another cohort study of 10 years follow up, by Kurth T et al32 in 
27,937 US women aged  > 45 years, to evaluate the association between 
various lipid parameters and the risk of ischemic stroke, it was seen that 
low HDL, LDL, Total cholesterol& TC/HDL ratio  were significantly 
associated with increased risk of ischemic stroke. 
 
In the present study, low HDL (47% in males & 96.7% in females) 
was more strongly associated with ischemic stroke than high TGL (34.3% 
in males & 40% in females). 
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Prevalence of metabolic syndrome 
Shrestha et al37 -   32% 
E.I. Sorkhou et al40 - 34% 
Milionis HJ et al &others33   -   46% 
Present study  - 53% 
            
 In  a cohort study done by Kurl S & et al30 in 1131men, patients 
with the metabolic syndrome as defined by the NCEP criteria had a 2.05-
fold risk for all strokes and 2.41-fold risk for ischemic stroke, after 
adjusting for socioeconomic status, smoking, alcohol and family history 
of coronary heart disease.  
 
In a cross-sectional analysis done by V. Athyros et al and others36 
in 9669 Greek adults, the age-adjusted CVD prevalence was compared in 
metabolic syndrome patients according to NCEP-ATP-III, IDF and 
AHA/NHLBI criteria. It was shown that CVD prevalence increased in the 
presence of metabolic syndrome irrespective of the definition used. 
However, this increase was more pronounced when the NCEP-ATP-III 
and AHA/NHLBI criteria were implemented compared with the IDF 
definition.  
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Sex and metabolic syndrome 
 In a study done by Hillier TA et al39 in older women (> 65 years) 
with diabetes, metabolic syndrome was associated with two- to threefold 
higher mortality risk due to CVD. This is in accordance with this study 
where 64% females above 60 years fulfilled the criteria for stroke. 
Further, several studies have shown females to have higher prevalence 
rate of metabolic syndrome than males in accordance with this study 
(73% vs. 44%).   
 
Metabolic parameters and Stroke 
In a prospective cohort study done by Koren-Morag N et al29 in 
14,284 patients with atherosclerotic cardiovascular disease to find  
relation between the metabolic syndrome and ischemic stroke or transient 
ischemic attack ,3703 (26%) had metabolic syndrome without diabetes 
and 3500(25%) had frank diabetes alone. The study showed that all 
components of the metabolic syndrome were associated with increased 
risk for ischemic stroke or TIA, but impaired fasting glucose and 
hypertension were the strongest risk predictors. 
 
In a study by Wolf et al6 in 2097subjects, between 51-80, 22% met 
the criteria for metabolic syndrome alone, 5% for diabetes alone and 5% 
had both conditions.  
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In comparison, in this study, 23% met the criteria for metabolic 
syndrome alone, 10.6% for diabetes alone, and 28% had both 
conditions.  
 
In a  cohort study done by Najarian et al34 in 2097 patients 
including 216 diabetic in Boston, it was found that 27.6 percent of the 
men and 21.5 percent of the women met the criteria for a diagnosis of 
metabolic syndrome without including IFG (IFG-126 mg %) patients.  
When 216 IFG individuals were included in the analysis, 30.3 percent of 
men and 24.7 percent of women met diagnosis criteria. The study 
concluded that metabolic syndrome and type 2 diabetes are independent 
risk factors for stroke. It was predicted that getting rid of their metabolic 
syndrome would eliminate about 20 percent of all strokes.  
 
In comparison, the present  study results show that 26% of the men 
and 18% of the women met the criteria for a diagnosis of metabolic 
syndrome without including  glucose criteria ( FBG >= 100 mg%) which 
increased to 74.2% & 81.8% in men & women respectively after 
including the glucose criteria. This huge increase in the prevalence of 
metabolic syndrome after applying the glucose criteria in our study is 
probably because of new modified definition of the syndrome used in the 
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study & also depicting the more potent contribution of prediabetes (IFG 
&IGT) to metabolic syndrome than other criterion factors. 
In a study by Gupta and co-workers31 which included 19,257 
hypertensive patients, 8091 (42%) were identified as having the 
metabolic syndrome at baseline according to the modified Adult 
Treatment Panel III (ATP III) criteria. When the individual components 
of the metabolic syndrome were adjusted, the metabolic syndrome was 
associated with a significantly increased risk for stroke as well as all-
cause mortality (p=0.03 and p=0.04, respectively). 
In contrast, in this study, out of 78 hypertensives, 48 (61.5%) had 
metabolic syndrome.  
 
In a study done by W. Lee et al and others38 using the Asia–Pacific 
criteria for abdominal obesity based on waist circumference (APC–WC: 
≥90cm in men, ≥80cm in women), prevalence rates of metabolic 
syndrome were 10.9% (9.8% male, 12.4% female), The age-specific 
prevalence of the metabolic syndrome increased in both male and female 
participants, and females had higher prevalence rates than males in age 
groups older than 50 years. 
 
In contrast, in our study, prevalence rates based on waist 
circumference were 30 %( 27% male, 43% female). 
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SUMMARY 
 
1) Ischemic stroke is the most common stroke pattern seen in Indian 
adults, more prevalent in males than in females; 80% being 
thrombotic episodes as compared to 12% hemorrhagic ones.  
2) The most common territory involved in both ischemic and 
hemorrhagic stroke was middle cerebral artery (85% and 16.7% 
respectively).Anterior cerebral artery was not involved in 
hemorrhagic stroke in this study. 
3) In both sexes, ischemic stroke had predilection for left middle 
cerebral artery (63%) whereas right middle cerebral artery (32%) 
was most frequently involved in hemorrhagic stroke. 
4) In females, sedentary life style (67%) was the most common 
contributory factor to stroke whereas in males, manual labourers 
were affected the most by stroke. 
5) In both sexes, stroke was most common in the age group>60 years 
(male-56%; females-73%). 
6) Mean age of stroke presentation in this study was 56+ 3 years in 
males and 63 + 4.2 years in females signifying earlier onset of risk 
factors in males as compared to females. 
7) The prevalence of hypertension in stroke patients was high  
        (77% males, 80% females). 
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8) The prevalence of diabetes (FBG >126 mg/dl) in stroke patients was 
higher in females (27%) than in males (17%). 
9) Mean triglyceride ( 140.6 + 7 mg/dl in males,147 + 9.8 mg/dl in 
females) and waist circumference ( 31+ 1.1 inches in males,30+ 1.4 
inches in females) were in the normal range in both sexes, whereas 
mean HDL cholesterol was well below the normal desired range 
(38.6+ 1.6 mg/dl in males,39+ 2.9mg/dl in females).  
10) In both sexes, mean blood pressure was in the stage I hypertensive 
range and mean fasting blood glucose was in the prediabetic range 
of 100-125 mg/dl suggesting that both hypertension and diabetes are 
independent strong risk factors for stroke and prediabetics are prone 
for macro vascular complications even before they are labeled as 
diabetics. 
11) Most common age group affected in males with FBG> 100 mg/dl 
was < 40 years (89%). 
12)  Most frequently affected age group by low HDL cholesterol and 
high blood pressure in males was > 60 years (62% & 90 
%respectively) and the same in females was 41-59 years (100% and 
88% respectively) emphasizing the high prevalence rate of 
metabolic syndrome in this age group.41-59 years was the most 
affected age group due to triglyceride (41%) and waist 
circumference (28%) parameters.  
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13) In females, the age group most frequently affected by FBG > 100 
mg/dl, Waist circumference and Triglyceride was > 60 years (64%, 
46%& 46 % respectively).  
14)  Overall the prevalence of Metabolic syndrome was 53%.It was 
more prevalent in females (73%) than in males (44%) & all the 5 
parameters affected them more than males. 
15)   Overall, blood pressure was the parameter that contributed most 
(80%) to metabolic syndrome followed by HDL cholesterol (62%) 
and FBG (56%) in that order. 
16) The parameter that contributed most to metabolic syndrome was 
high blood pressure in males and low HDL cholesterol in females. 
17)  In this study, none of the females smoked or consumed alcohol. In 
males, 73% were smokers and 74% were alcoholics; but only 37% 
and 44% respectively had metabolic syndrome. Further, 63% non 
smokers and 44% non alcoholics had metabolic syndrome. This 
implies that though smoking and alcohol are important risk factors 
for stroke, they don’t contribute to metabolic syndrome in a 
significant way.   
18)  Ischemic stroke was the most common stroke pattern observed in 
metabolic syndrome patients. 
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19)  Prevalence of both diabetes & hypertension was seen in 19% stroke 
patients which increased to 26% in metabolic syndrome patients 
signifying the consistent strong association between these two 
factors & their strong contribution to the syndrome. 
20) HDL Cholesterol significantly contributed to the syndrome in both 
sexes (73% in males & 72% in females). Also, % of metabolic 
syndrome patients associated with abnormal HDL levels was also 
significant (77% in male metabolics &96% in female metabolics). 
All females with normal HDL levels were non metabolic and only 
19% males with normal HDL levels had metabolic syndrome.  So 
both HDL and metabolic syndrome were strongly associated with 
each other. 
21)  Triglyceride levels significantly contributed to the syndrome in both 
sexes (83% in males & 92% in females).Also, metabolic syndrome 
was associated significantly with high triglyceride in both sexes 
(65% in males &50 % in females). But 24% males &61% females 
with normal TGL levels conversely had metabolic syndrome. Both 
high TGL & Metabolic syndrome were associated with each other 
but not as strong as low HDL & high blood pressure. 
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22) Waist circumference significantly contributed to the syndrome in 
both sexes (90% in males & 100% in females). Also, % of 
metabolic syndrome patients associated with abnormal waist 
circumference was significant in both sexes (55% in males &60 % in 
females). But 28% males & 53% females with normal waist 
circumference had metabolic syndrome. All female patients with 
abnormal waist circumference had metabolic syndrome and all non- 
metabolics had normal waist circumference showing strong 
association between waist circumference and metabolic syndrome in 
them. 
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CONCLUSION 
¾ Ischemic stroke with involvement of left middle cerebral artery is 
the most common stroke seen in Indian adults, affecting most 
commonly sedentary females and male manual labourers in the age 
group > 60 years. 
¾ Hypertension, Diabetes and low HDL levels are the most important 
risk factors for stroke, more so in females. 
¾ Males in age group 41-59 years are at increased risk of metabolic 
syndrome due to all parameters a little earlier than females who are 
at risk above 60 years. 
¾ Indians have high prevalence rate of metabolic syndrome (53%) 
affecting females more than males. 
¾ Blood pressure is the most common contributing factor to the 
syndrome. 
¾ All factors significantly contribute to the syndrome but metabolic 
syndrome is strongly associated with high blood pressure, impaired 
fasting glucose and low HDL levels only, except in females in 
whom the syndrome & waist circumference are strongly 
associated.  
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PROFORMA 
STUDY OF METABOLIC SYNDROME IN STROKE PATIENTS 
(NCEP ATP III MODIFIED CRITERIA) 
   
NAME     : 
 
AGE        :    
   
SEX         :                                     MALE / FEMALE 
 
ADDRESS: 
 
OCCUPATION :   SEDENTARY  
MODERATE ACTIVITY 
MANUAL LABOURER 
 
RISK FACTORS   : 
 
1. FASTING BLOOD GLUCOSE (mg/dl) 
 
2. FASTING LIPID PROFILE                  HDL-C (mg/dl):                       
TGL (mg/dl): 
 
 
3. WAIST CIRCUMFERENCE (inches):       
 
4. HIP MEASUREMENT: 
 
 
5. WAIST HIP RATIO: 
 
6.  BODY MASS INDEX:              WEIGHT:            HEIGHT: 
 
7. BLOOD PRESSURE (mmHg): 
 
8.  ECG:  
 
9.  ECHO: 
 
10.  SMOKING;                                                            YES / NO 
 
11.   ALCOHOL:                                                         YES/NO 
 
   
 
 
 
 
  
  
 
 
12. ACANTHOSIS NIGRICANS                               YES/NO 
 
13:  CT BRAIN 
 
 
DIAGNOSIS:                             ISCHEMIC  
HEMORRHAGIC  
UNCLASSIFIED 
 
TREATMENT: 
 
OUTCOME                               DEATH   / RECOVERY 
 
NOTE:  
OCCUPATION 
Sedentary  - Unemployed at home, Office workers, 
Professional. 
Moderate activity  -  Semiskilled and skilled professionals               
like weavers, drivers, workshop -             
worker, cobbler, salesman, broker,                     
carpenter etc 
Manual labourers  -  Unskilled daily wagers, farmers, building 
construction workers etc. 
 
 
 
 
